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Abstract
Major depressive disorder (MDD) is the 
most prevalent type of mental illness, and is 
characterized by the presence of such symptoms 
as depressive mood, diminished interest or plea-
sure, insomnia, fatigue and diminished ability 
to think or to concentrate.  Patients with MDD 
are at high risk for suicide, and are among the 
most common cases of hospitalization in ad-
vanced countries.  MDD is a complex disease, 
in which multiple genetic factors are involved 
in the disease predisposition, and environmen-
tal factors cause the onset.  Elaborate studies 
have been conducted to uncover the pathogen-
esis of MDD.  However, lack of knowledge on 
the physiology and molecular basis of human 
depression have prevented the understanding 
of this disease.  Establishing animal model of 
MDD has been highly challenging because of 
the difficulty to define the common endopheno-
types in mice and humans that underlie the de-
pression in humans.  We have been studying the 
effects of aberrant light/dark cycles on the be-
havioral phenotypes of laboratory mice.  Lab-
oratory mice maintained under normal light/
dark cycles show a daily rhythm of activity that 
is precisely synchronized to the environmental 
light/dark cycles.  When maintained in aber-
rant light/dark cycles, they show a lengthened 
rhythm of activity that is governed by the in-
trinsic circadian timing system, and they lose 
the ability to adjust to the environmental light/
dark cycles.  These mice showed an impaired 
saccharine preference, which is a phenotype as-
sociated with anhedonia, one of the diagnostic 
symptoms of MDD.  Mouse under aberrant 
light/dark cycles will serve as a useful model of 
MDD and will contribute to the understanding 
and treatments of MDD. 
1  Introduction
Major depressive disorder (MDD) is the 
most common form of the mood disorder.   It 
is estimated that over 340 million people are af-
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fected by MDD, and nearly 10 % of every hu-
man populations suffer from MDD in the life-
time [1].  Patients with MDD are at high risk of 
suicide, and cares of MDD patients are heavy 
burden for their families as well as for the soci-
ety.  According to the “Diagnostic and Statisti-
cal Manual of Mental Disorders” by the Ameri-
can psychiatric association (DSM-IV), MDD is 
classified under the category of depressive dis-
order.  Table 1 shows the position of MDD in 
the taxonomic hierarchy of mood disorders [2]. 
Table 2 summarizes the diagnostic criteria for 
MDD.  Patients with depressed mood and/or 
loss of interest or pleasure for at least 2 weeks, 
and those with at least five of the nine symp-
toms listed in Table 2 are diagnosis as MDD [2].
2.  Pathophysiology of MDD
Patients with mood disorders including 
MDD have been treated with various types of 
anti-depressants such as monoamine oxidase 
inhibitors (MAOIs) and tricyclic antidepres-
sants for nearly 50 years.  Current hypothesis of 
the pathophysiology of MDD is based on the 
understanding of the possible effects of these 
antidepressants on the neurotransmitters such 
as serotonine, noradrenaline and dopamine in 
the synaptic gap of nerve terminal (Fig. 1).  
MAOIs such as iproniazid have been known 
to inhibit the catabolic process of neurotrans-
mitters in the presynaptic neuron, and were 
thereby assumed to contribute to the elevat-
ed concentrations of neurotransmitters in the 
synaptic gap [3, 4].  On the other hand, tricy-
clic antidepressants such as imipramine were 
shown to inhibit the function of monoamine 
transporters which are responsible for uptake 
of neurotransmitters in the synaptic gap, and 
have thereby been assumed to contribute to the 
maintenance of neurotransmitters in the synap-
tic gap [5].  Based on these understandings, it was 
proposed that decreased concentration of neu-
rotransmitters in the synaptic gap of nerve ter-
minal is the major cause of the neuronal defect 
linked to MDD [6].  This hypothesis is called the 
“Monoamine Hypothesis” and has been widely 
accepted.  However recently, accumulating ev-
idences suggested that this hypothesis alone is 
not adequate to explain the pathophysiology of 
the disease [3].  Further studies are needed to un-
derstand the cause of MDD and to develop its 
effective treatments.
3.  Pathogenesis of MDD
MDD is thought to be a complex disease, 
in which multiple genetic factors form the basis 
of the disease and non-genetic factors such as 
the experience of mental trauma or stress cause 
Table 1. Category of Mood Disorders according to 
DSM-Ⅳ 
 Depressive Disorder 
  Major depressive disorder 
  Dysthymic disorder 
  Depressive disorder not otherwise specified
 Bipolar Disorders 
  Bipolar Ⅰ disorder
  Bipolar Ⅱ disorder 
  Cyclothymic disorder
  Bipolar disorder not otherwise specified
 Other Mood Disorders
  Mood disorder due to a general medical condition
  Substance induced mood disorder
  Mood disorder not otherwise specified
 
Table 2. Diagnostic criteria for MDD according to 
DSM Ⅳ
(1) depressed or irritable mood
(2) decreased interest or loss of pleasure
(3) weight gain or loss
(4) insomnia or hypersomnia
(5) psychomotor retardation or agitation
(6) fatigue or loss of energy
(7) feelings of worthlessness or inappropriate guilt
(8) diminished ability to think or concentrate
(9) recurrent thoughts of death and suicide 
Five or more of the 9 symptoms need to be pres-
ent during the same 2-week period to be diagnosed 
as MDD.  At least one of the symptoms is either (1) 
depressed mood or (2) loss of interest or pleasure. 
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the onset.  As to the genes involved in the sus-
ceptibility to mood disorders, polymorphism of 
the promoter region of serotonin-transporter 
gene was reported to associate with bipolar dis-
order, suicidal behavior and depression-related 
personality traits [7].  However, in spite of the 
international enormous efforts of genome-wide 
association studies using 1.2 million autosomal 
and X chromosome single-nucleotide polymor-
phisms (SNPs), no single locus was identified to 
be significantly linked to MDD [8] suggesting the 
extreme complexities of the genes involved in 
susceptibility to MDD.
4.  Mouse models of MDD
For the research of this type of multifacto-
rial disease, animal model is valuable.  Estab-
lishment of mouse MDD model is highly chal-
lenging. As mice do not speak, it is impossible 
to communicate with mice to know their mood 
and physiological conditions.  However, some 
behaviors and “endophenotypes” associated 
with the symptoms of MDD may be measured 
quantitatively in mice.  For example, weight loss 
is easily measured in mice.   Psychomotor re-
tardation, fatigue or loss of energy is also mea-
sured as the decreased activity of locomotion of 
mice in their cages [9].   Anhedonia, which is the 
loss of the ability to feel the pleasing sense, is 
associated with MDD and underlies one of the 
diagnostic symptoms of MDD.  An endophe-
notype associated with anhedonia is measured 
in rodents by the saccharine preference test [10]. 
4.1  Mouse Stress Models
Various stressful conditions have been ap-
plied to mice to induce phenotypes associated 
with depression.  In early studies, researchers 
used the stresses such as forced swimming [11] 
or tail suspension [12] to induce the depressed 
states of mice.  Chronic social defeat stress [13] 
is a condition in which a mouse is repeatedly 
exposed to aggressive dominant animals.  Aber-
rant light/dark cycle stress [14] is a type of mild-
stress recently preferred by the researcher due to 
the awareness of the animal ethics.  We are also 
studying this stress model. 
4.2  Aberrant Light/Dark Cycle Stress
Figure 2 compares the actograms of mice 
placed under normal 12h:12h light-dark cycles 
(T24 control cycle) and aberrant 3.5h:3.5h light-
dark cycles (T7 cycles).  Daily activity of mouse 
in the cage is monitored by infrared sensor. In 
these actograms, each row shows the day in the 
experiment beginning from the top.  Horizontal 
axis shows the time in the day.  In the normal 
T24 cycles, mice showed normal rhythms of ac-
tivity in which their intrinsic circadian rhythms 
are synchronized with environmental light/dark 
Fig. 1. 
“Monoamine hypothesis” of mood disorders 
supposes that depression is caused by the deficiency 
of neurotransmitters, which include serotonin, nor-
epinephrine and dopamine.  Monoamine oxidase 
inhibitors  (MOI)  inhibits the catabolic process of 
neurotransmitters and contribute to the increased 
con- centration of neurotransmitters.  On the other 
hand, tricyclic antidepressants such as imipramine 
were known to inhibit the function of monoamine 
trans- porters which are responsible for uptake of 
neurotransmitters in the synaptic gap, and have 
thereby been assumed to contribute to the mainte-
nance of neurotransmitters in the synaptic gap.  
Fig. 1  Haga et al.
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cycles.  On the other hand, as was first reported 
by LeGates and Hatter (2012) [14], mice under T7 
cycles lost their capacity to synchronize their 
circadian rhythms to environmental light/dark 
cycles as evidenced by lengthened rhythms gov-
erned only by the intrinsic circadian timing sys-
tem.  This results in the gradual shifts of their 
activity rhythms from the daily cycles.
Figure 3 shows the results of saccharine 
preference test of mice that were maintained 
in the aberrant T7 cycles.  In this experiment, a 
mouse can choose either normal water or sweet-
ened water freely to drink from each of the two 
bottles.  Varied concentrations of saccharine 
solutions were tested.  When sweetened waters 
with saccharine concentrations higher than 
0.04% were used, mice both under control T24 
and T7 cycles preferred sweetened water.  How-
ever, when 0.0125% saccharine solution was 
used, mice maintained under T7 cycles did not 
show preference, while mice under control T24 
cycles still showed saccharine preference.  This 
is the evidence that mice under T7 cycles had 
impaired sense for a pleasant signal, a pheno-
type associated with anhedonia.  
Conclusion
Mice maintained under aberrant light/dark 
cycles (T7 cycles) showed one of the symptoms 
of the major depressive disorder (MDD), and 
will serve as a potential model to study the 
pathophysiology of MDD.  We are currently 
studying the effects of T7 cycles on the rhyth-
mic cycles of Clock gene transcriptions in the 
peripheral tissue. We have preliminary evidence 
that daily rhythmic cycles of Clock gene tran-
scription is disrupted in the peripheral tissue of 
mice maintained under T7 cycles.  Our finding 
Fig. 2.  General activity rhythms of 
mice under normal (T24) and ab-
errant (T7) light/dark cycles.  Two-
months old C57BL/6 male mice are 
individually housed in a cage where 
locomotion activity is monitored by 
infrared sensor.  The light intensity 
during the light period was 800 lx.  











Fig. 2  Haga et al.
Fig. 3. 
Results of the saccharine preference tested by various 
concentrations of sodium saccharine. Two-months old 
C57BL/6 male mice are individually caged in either nor-
mal T24 or aberrant T7 cycle for two weeks.  Subsequent-
ly, two bottles that supply normal water and sweetened 
water were placed in the cage, while the light/dark cycles 
were continued.  Consumptions of the water and sweet-
ened water were measured after 24 hrs. 
Fig. 3  Haga et al.
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may be a clue to understand the cause-effect re-
lationship in the pathophysiology of MDD. 
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